Participated · Series B · Sep 2022

Sanity Group, founded in Berlin in 2018, develops medicinal cannabis, wellbeing and cosmetic cannabinoid products and operates brands/subsidiaries such as AVAAY Medical, Vayamed, Endosane Pharmaceuticals and VAAY. The company maintains a large German distribution network of over 2,000 pharmacies and works with approximately 5,000 physicians, holding roughly a 10% share of the German medical cannabis market; its AVAAY medical brand is estimated to be number two. Sanity is participating in a Swiss recreational cannabis pilot in Basel with one store operational and plans to expand its retail footprint in Switzerland. The company intends to invest in proprietary distribution channels to capture new medical consumers and is planning initiatives expected to provide access to over 100,000 patients and support recreational pilot expansion. Sanity’s product mix spans pharmaceuticals, medical cannabis, and wellbeing/cosmetic offerings, and it operates a storage facility near Frankfurt for extracts and flower. Sanity Group develops medicinal cannabis, finished pharmaceuticals, medical products, digital applications, wellbeing products and natural cosmetics that utilize cannabinoids and the endocannabinoid system. The group comprises Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (finished pharmaceuticals), Belfry Medical (medical products and digital applications), VAAY (wellbeing) and This Place (natural cosmetics). It operates a production and processing facility for cannabis extracts near Frankfurt am Main and employs around 120 people across medical, consumer health and science functions. Founded in Berlin in 2018, the company aims to improve quality of life through cannabinoid-based products and therapies. Sanity Group plans to use new funding to accelerate growth, enable European expansion and strengthen research and development. The company has raised over $100 million in total funding to date. Sanity Group is a Berlin-based cannabis and digital health startup that builds a cannabis-based platform for mental health and chronic pain management. Its offering includes a medical device and digital therapy diary that tracks administered active ingredients (THC, CBD and other cannabinoids) to quantify dosing. The company closed a $44.2M Series A, bringing total funding to $73M; the round is reported as the largest cannabis funding round in Europe to date. Proceeds will be used to expand the Group’s medical division in Europe and to build an EU‑GMP‑compliant research and production facility near Frankfurt. Management says it is expanding geographically into the Czech Republic and Poland, targeting the U.K., and expects France to open next year. Prior investors include HV Capital, TQ Ventures, Atlantic Food Labs, Cherry Ventures, Bitburger Ventures and SevenVentures, and celebrity angels include will.i.am, Scooter Braun and Alyssa Milano. Sanity Group is a Berlin-based medical cannabis and wellness company operating two business units: Sanatio Pharma, focused on developing new medical cannabis therapies and pharmaceuticals, and VAAY, a consumer wellness brand. The company is fully licensed and currently operational. Founded in 2018 by Finn Hänsel and Fabian Friede, Sanity Group combines medical and consumer wellness offerings. It completed a €20m funding round to support strategic initiatives. The funds will be used to drive projects that expand access to medical and medically-related cannabis products and advance its product programs.

Led · Seed · Jul 2021

Trading.TV is a social livestream and immersive chat platform purpose-built for traders and financial content creators, led by CEO and founder Tobias Heaslip. The platform launched out of stealth in August 2021 and is publicly available on iOS, Android and desktop. Features include front and back camera live streaming, video uploading and short-form recording, synchronous voice chat, Plaid integration, a native digital currency called Digis, and stock trading with paper trading available today and real-money trading coming soon. The company works with financial creators and brands to provide content and community for investors across a variety of assets. Trading.TV announced a $1M Creator Fund in July 2021 to support early creators and plans to grow that fund significantly by allocating up to 10% of platform revenue. The new capital will be used to expand the team and continue building the platform. Trading.TV is the world’s first social livestream and immersive chat platform purpose-built for traders and financial content creators. The platform enables creators to develop and share content across asset classes, from stocks and crypto to NFTs and rare sneakers, with live streaming and community chat features. Trading.TV is hand-picking its first 50 creators for a closed beta and has launched a $1M Creator Fund to support the initial cohort. The company says it will eventually offer a commission-free trading capability so community members can act on creator-driven ideas. Trading.TV will use its seed funding to build the team and invest in platform growth ahead of a public release in the fall. The company emphasizes inclusion and financial education to expand access and engagement among younger and underrepresented audiences.

Participated · Equity · Jul 2021

C3 Industries is an Ann Arbor, Mich.-based multi-state, vertically integrated cannabis company that produces the Cloud Cover Cannabis brand and operates the High Profile retail network. The company produces products across all categories in Oregon and Michigan and is preparing launches in Massachusetts and Missouri. It currently has eleven retail locations fully approved in Michigan and multiple additional locations under development. C3 has previously closed more than $40M in private rounds, bringing total capital raised to roughly $65M to date. The company intends to use the new funds to accelerate expansion in existing markets, enter new states organically and via M&A, and invest in its team, brands and business infrastructure as it scales. C3 Industries is a vertically integrated cannabis company producing and retailing premium cannabis products under the Cloud Cover Cannabis brand and operating a retail network called High Profile. Led by Ankur Rungta (CEO), Vishal Rungta (President and CFO) and Joel Ruggiero (Chief Horticulture Officer), the company runs cultivation and manufacturing facilities and is pursuing branded dispensaries. The company plans a three‑state strategy focused on Oregon, Michigan and Massachusetts and has submitted cultivation, processing and retail license applications in Missouri. C3 is expanding capacity: a new 35,000-square-foot cultivation and manufacturing facility in Webberville, Mich. is opening this month, additional production capacity is under development, and a 37,000-square-foot Franklin, Mass. facility is beginning construction. In Oregon it operates a 36,000-square-foot cultivation facility (operating for the past 18 months), is beginning construction on a hydrocarbon extraction lab, and recently closed an acquisition for a branded dispensary in Portland subject to regulatory approval. Financially, the company closed a round of private financing and has raised more than $25m in total capital to date; it intends to use funds to continue expanding in existing markets and enter new ones.

Led · Equity · Apr 2021

Connected Cannabis Co. is a premier cannabis cultivator, retailer and market leader in California. The company breeds, grows and sells proprietary top‑shelf cannabis strains and operates state‑of‑the‑art indoor grow facilities in California and Arizona. Connected began in 2009 as Fruitridge Health and Wellness in Sacramento and was co‑founded by master grower Caleb Counts. Its celebrated strains have a cult‑like following and its indoor flower commands the highest wholesale price in major legal markets. Connected acquired the popular brand Alien Labs in 2017 and today operates three stores. The company recently closed a $30 million capital raise consisting of debt and equity financing led by existing backers.

Participated · Seed · Jan 2020

Cann Social Tonics produces microdosed, non-alcoholic THC-infused beverages designed to deliver an uplifting buzz comparable to a beer or glass of wine. Its drinks are vegan, gluten-free, low in calories, contain five all‑natural ingredients, and omit artificial sweeteners, flavors, preservatives, and a cannabis taste. Since launching in 2019 in Los Angeles, Cann has sold its 10 millionth can and is available across multiple U.S. states and parts of Canada. The brand has won industry recognition (BevNET New Beverage Showdown, 2019) and is backed by a roster of celebrity investors including Gwyneth Paltrow, Kate Hudson, Baron Davis, Rebel Wilson, Rosario Dawson and others. Management and InvestBev state the company aims to integrate safe, approachable cannabis beverages into mainstream beverage channels with expanded distribution and operational support. Cann produces low‑THC cannabis beverages (an 8‑ounce can contains 2mg THC and 4mg CBD) and offers a range of products including THC‑infused syrups and cannabis‑free tonic waters. Its core positioning is as a drinkable alternative to alcohol, though price points (a California 6‑pack retails for $20) and state cannabis taxes make it costlier than mainstream beer or spiked seltzers. The company currently sells in California, Massachusetts, Rhode Island, Nevada and Illinois and is expanding internationally into Canada, beginning with Ontario. Cann has experimented with multiple SKUs and pack sizes (including 12‑packs of tonic waters) to find market fit. The business has raised institutional and celebrity investor backing and previously closed a $5M seed round in 2020; the articles also note the company has moved roughly 150,000 units. Regulatory limits on cannabis markets constrain where Cann can expand next. Cann produces a cannabis-infused social tonic that balances 2 mg of THC and 4 mg of CBD per can, designed to deliver a feeling of vigor and well-being in about 10 minutes. The tonic contains 30–35 calories and is made from five all-natural ingredients; products are non-GMO and contain no gluten, added sugars, concentrated juices, or artificial flavors. Led by Luke Anderson and Jake Bullock, the company is stocked in over 60 dispensaries throughout California and is available for delivery across the state via Eaze. Cann plans to use its recently raised capital to grow across California and enter new legal state markets, expand production capacity, and broaden and accelerate product development. The company is based in Los Angeles, CA. Cann produces microdosed THC and CBD-infused beverages (2 mg THC and 5 mg CBD per can) sold in $30 multi-flavor six-packs with herbaceous and floral flavor profiles. The company launched with a soft June release across four MedMen stores in Los Angeles and is rolling out broader distribution through the delivery service Eaze in California. Founders Jake Bullock and Luke Anderson are former Bain consultants who developed the product after fundraising through the fall. Cann raised $1.5 million from investors to support the launch and early distribution. The founders emphasize learning purchase and repurchase behavior from small releases and plan to expand retail and delivery reach. They have engaged with 4thMVMT as part of efforts to support communities harmed by the War on Drugs and link the business to social-impact goals.